<DOC>
	<DOCNO>NCT01588574</DOCNO>
	<brief_summary>The purpose study determine Optimal dose safety efficacy treatment cervical dystonia .</brief_summary>
	<brief_title>Study Determine Safety Efficacy Clostridium Botulinum Toxin Type A Subjects With Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Male female age 18~75 Have clinically significant medical condition Cervical dystonia Pregnant lactation Subjects administer follow drug within previous 1 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>